van de Ven, Cesca
14  results:
Search for persons X
?
7

Ibrutinib is not an effective drug in primografts of TCF3-P..:

Ven, Cesca ; Boeree, A ; Stalpers, Femke..
Ven , C , Boeree , A , Stalpers , F , Zwaan , C M & den Boer , M 2020 , ' Ibrutinib is not an effective drug in primografts of TCF3-PBX1 ' , Translational Oncology , vol. 13 , no. 10 , 100817 . https://doi.org/10.1016/j.tranon.2020.100817.  , 2020
 
?
9

RAS pathway mutations as a predictive biomarker for treatme..:

Jerchel, Isabel ; Hoogkamer, Alex ; Aries, Ingrid...
Jerchel , I , Hoogkamer , A , Aries , I , Steeghs , L , Boer , J , Besselink , N J M , Boeree , A , Ven , C , de Groot-Kruseman , HA , de Haas , V , Horstmann , MA , Escherich , G , Zwaan , C M , Cuppen , E , Koudijs , MJ , Pieters , R & den Boer , M 2018 , ' RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia ' , Leukemia , vol. 32 , no. 4 , pp. 931-940 . https://doi.org/10.1038/leu.2017.303.  , 2018
 
?
10

JAK2 aberrations in childhood B-cell precursor acute lympho..:

Steeghs, Lieneke ; Jerchel, Isabel ; Nobel, Willemieke...
Steeghs , L , Jerchel , I , Nobel , W , Hoogkamer , A , Boer , J , Boeree , A , Ven , C , Koudijs , MJ , Besselink , N J M , de Groot-Kruseman , HA , Zwaan , C M , Horstmann , MA , Pieters , R & den Boer , M 2017 , ' JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia ' , Oncotarget , vol. 8 , no. 52 , pp. 89923-89938 . https://doi.org/10.18632/oncotarget.21027.  , 2017
 
?
12

Ibrutinib is not an effective drug in primografts of TCF3-P..:

Cesca van de Ven ; Aurélie Boeree ; Femke Stalpers..
http://www.sciencedirect.com/science/article/pii/S1936523320303090.  , 2020
 
1-14